Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07694206 · ClinicalTrials.gov registry record
Digital and Plasma Biomarkers in Delirium
A clinical trial, sponsored by Scripps Health.
- Recruiting
- Registry status
- 100
- Enrollment target
NCT07694206: Recruiting study, sponsored by Scripps Health.
NCT07694206 is a clinical trial that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07694206 is actively recruiting participants, sponsored by Scripps Health.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn if there are potential digital and plasma-based biomarkers that could help detect, predict, and prognosticate delirium in older adult patients who are admitted to the intensive care unit (ICU). The main question DELTA aims to answer is: Can digital biometrics predict and detect delirium in older adult ICU patients? Do biomarkers of neurodegeneration fluctuate in ICU patients in such a way that delrium could potentially be predicted? Participants admitted o the ICU will wear a digital device to collect biometric data and will have serial plasma samples collected during ICU admission and patients will be also assessed for delirium daily by study staff.
Primary Outcome
Delirium incidence as assessed by the CAM-ICU instrument.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-05-28 |
| Est. Completion | 2027-12-31 |
What NCT07694206 shows while recruiting
NCT07694206 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07694206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07694206 about?
NCT07694206 is a clinical study titled "Digital and Plasma Biomarkers in Delirium". The goal of this observational study is to learn if there are potential digital and plasma-based biomarkers that could help detect, predict, and prognosticate delirium in older adult patients who are admitted to the intensive care unit (ICU). The main question DELTA aims to answer is: Can digital b...
What is the current status of trial NCT07694206?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-05-28. Estimated completion is 2027-12-31.
Who is sponsoring clinical trial NCT07694206?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI